Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$7.06 - $23.63 $18,179 - $60,847
-2,575 Reduced 0.4%
647,747 $5.42 Million
Q1 2022

May 10, 2022

SELL
$21.6 - $27.79 $254,880 - $327,922
-11,800 Reduced 1.78%
650,322 $14.9 Million
Q4 2021

Feb 07, 2022

SELL
$23.0 - $29.01 $202,285 - $255,142
-8,795 Reduced 1.31%
662,122 $18.3 Million
Q3 2021

Oct 29, 2021

SELL
$25.04 - $30.06 $99,158 - $119,037
-3,960 Reduced 0.59%
670,917 $18.7 Million
Q2 2021

Jul 27, 2021

SELL
$27.43 - $32.7 $482,356 - $575,029
-17,585 Reduced 2.54%
674,877 $19.8 Million
Q1 2021

Apr 23, 2021

SELL
$21.37 - $34.38 $668,453 - $1.08 Million
-31,280 Reduced 4.32%
692,462 $22 Million
Q4 2020

Jan 28, 2021

SELL
$15.31 - $21.12 $728,296 - $1 Million
-47,570 Reduced 6.17%
723,742 $15.1 Million
Q3 2020

Oct 28, 2020

BUY
$14.88 - $20.13 $2.29 Million - $3.09 Million
153,596 Added 24.87%
771,312 $12 Million
Q2 2020

Aug 04, 2020

BUY
$13.31 - $20.51 $1.56 Million - $2.4 Million
117,035 Added 23.38%
617,716 $11.3 Million
Q1 2020

May 12, 2020

SELL
$12.98 - $30.25 $8,943 - $20,842
-689 Reduced 0.14%
500,681 $7.76 Million
Q4 2019

Feb 05, 2020

SELL
$18.89 - $31.89 $14,167 - $23,917
-750 Reduced 0.15%
501,370 $15 Million
Q3 2019

Oct 25, 2019

SELL
$20.88 - $25.66 $204,624 - $251,468
-9,800 Reduced 1.91%
502,120 $11 Million
Q2 2019

Aug 05, 2019

BUY
$20.52 - $26.45 $8.38 Million - $10.8 Million
408,165 Added 393.39%
511,920 $12.9 Million
Q1 2019

Apr 29, 2019

SELL
$20.23 - $26.29 $115,311 - $149,853
-5,700 Reduced 5.21%
103,755 $2.56 Million
Q4 2018

Feb 07, 2019

SELL
$17.64 - $28.32 $38,808 - $62,304
-2,200 Reduced 1.97%
109,455 $2.02 Million
Q3 2018

Oct 23, 2018

BUY
$20.64 - $25.67 $2.3 Million - $2.87 Million
111,655 New
111,655 $2.87 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.33B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Terril Brothers, Inc. Portfolio

Follow Terril Brothers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Terril Brothers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Terril Brothers, Inc. with notifications on news.